Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human fusariosis.

M C Dignani1, E Anaissie

  • 1FUNDALEU (Foundation for the Fight against Leukemia), Uriburu 1450, Buenos Aires, Argentina.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MicroRNA theragnostics for the clinical management of multiple myeloma.

Leukemia·2014
Same author

Improvement in the outcome of invasive fusariosis in the last decade.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
Same author

Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

An unusual clinical course of cardiac Ig deposition disease.

Bone marrow transplantation·2009
Same author

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2009

Fusarium infections pose risks, especially to immunocompromised individuals. Early detection of skin lesions and antifungal treatment are crucial for managing fusariosis and improving patient outcomes.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Fusarium species are significant fungal pathogens causing human infections.
  • Risk factors vary between immunocompetent and immunocompromised patients.

Purpose of the Study:

  • To review the epidemiology, clinical manifestations, diagnosis, and treatment of fusariosis.
  • To highlight the importance of host immune status in patient outcomes.

Main Methods:

  • Literature review of Fusarium infections in humans.
  • Analysis of risk factors, clinical presentations, and diagnostic methods.
  • Summary of treatment strategies and preventive measures.

Main Results:

  • Fusarium infections range from localized (keratitis, onychomycosis) to disseminated disease.

Related Experiment Videos

  • Immunocompromised patients, particularly those with hematological malignancies, face higher risks and mortality.
  • Skin lesions are key diagnostic indicators, often preceding fungemia.

    • Conclusions:

    • Host immune status is the primary determinant of fusariosis outcome.
    • Prompt diagnosis and targeted antifungal therapy are essential.
    • Preventive strategies include minimizing environmental exposure and managing skin integrity.